Document Detail


Edaravone attenuates ischemia-reperfusion injury by inhibiting oxidative stress in a canine lung transplantation model.
MedLine Citation:
PMID:  18982873     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Previous reports have confirmed that edaravone has protective effects against ischemia-reperfusion (IR) injury of many organs. In this study, we investigated the effect of edaravone on preventing IR injury of the lung in a canine lung transplantation model. METHODS: Twelve weight-matched pairs of random-bred dogs were randomized into two groups. Within each pair, one dog served as donor and the other as recipient. In the study group, prostaglandin E1(PGE1)(8 microg/kg) was injected into the donor pulmonary artery (PA) before occlusion and the donor lungs were flushed with 1.0 L of LPD solution containing edaravone (10 mg/kg) and stored in the same LPD solution at a temperature of 1 degrees C for 8 hours. The left single lung transplantation was then performed and recipients received intravenous injection with edaravone (10 mg/kg) at the onset of reperfusion. In the control group, edaravone was substituted by the same volume of sterile saline solution. Another six dogs were obtained as normal control group in which left lungs were dissected after thoracotomy without an IR injury. One hour after reperfusion, or after dissection of the left lung, the right lung was excluded from perfusion and ventilation after which, cardiopulmonary parameters were measured. Wet/dry ratios, malondialdehyde (MDA) and myeloperoxidase (MPO) levels were assessed and histological analysis of lung tissue performed at the same time. RESULTS: All animals survived until the end of the experiment. The study group showed significantly decreased wet/dry ratios (treated: (74.1 +/- 4.2)% vs control: (86.8 +/- 5.2)%, P < 0.01), MDA levels (treated: 0.50 +/- 0.08 vs. control: 0.88 +/- 0.15, P < 0.01) and MPO activity (treated: 0.23 +/- 0.05 vs. control: 0.43 +/- 0.07, P < 0.01) compared to the control group two hours after occlusion of the right side. In the control group, pulmonary vascular resistance (PVR) was increased markedly and arterial oxygen partial pressure deteriorated significantly after exclusion of the right side compared to those in the treatment group. CONCLUSIONS: Edaravone attenuates IR-induced lung injury and preserves lung function by inhibiting oxidative stress and decreasing leukocyte extravasation in a canine lung transplantation model.
Authors:
Jin-zhi Xu; Bao-zhong Shen; Ye Li; Tong Zhang; Wan-hai Xu; Xiao-wei Liu; Hong-guang Lu
Related Documents :
2831433 - Eicosanoids are involved in the permeability changes but not the pulmonary hypertension...
7429903 - Lung inflation can cause pulmonary edema in zone i of in situ dog lungs.
678343 - Renin-sodium profile and its therapeutical implications in arterial hypertension.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Chinese medical journal     Volume:  121     ISSN:  0366-6999     ISO Abbreviation:  Chin. Med. J.     Publication Date:  2008 Aug 
Date Detail:
Created Date:  2008-11-05     Completed Date:  2008-11-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7513795     Medline TA:  Chin Med J (Engl)     Country:  China    
Other Details:
Languages:  eng     Pagination:  1583-7     Citation Subset:  IM    
Affiliation:
Department of Thoracic Surgery, Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China. xujinzhi003@vip.qq.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antipyrine / analogs & derivatives*,  pharmacology,  therapeutic use
Disease Models, Animal
Dogs
Lipid Peroxidation
Lung / metabolism,  pathology
Lung Transplantation / adverse effects*
Nitric Oxide / biosynthesis
Oxidative Stress / drug effects*
Peroxidase / metabolism
Reperfusion Injury / prevention & control*
Chemical
Reg. No./Substance:
10102-43-9/Nitric Oxide; 60-80-0/Antipyrine; 89-25-8/phenylmethylpyrazolone; EC 1.11.1.7/Peroxidase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevalence of high-risk human papillomavirus infection in different cervical lesion among organized ...
Next Document:  Statin alternatives or just placebo: an objective review of omega-3, red yeast rice and garlic in ca...